Related posts
Most Anticipated Earnings: UNC-T, DAN-X and more Canadian Companies Reporting Earnings this Week (Nov 27-Dec 01)Most Anticipated Earnings: MAI-X, FOOD-T and more Canadian Companies Reporting Earnings this Week (Nov 20-24)Kinross Gold, Northland Power Inc and More at 52-week Highs (Sep 16-22)Tele-health company.
Has sold shares. Very high valuations.
Path to profitability slower than expected.
Recently selling assets.
Not sure path to profitability.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Revenue grew by 461% year over year. However, EPS missed estimates. It is growing extremely fast and organic growth is forecasted to be driven by partner relationships. The balance sheet is growing rapidly and top-line growth should outpace operating expenses. Unlock Premium - Try 5i Free
CloudMD is a Canadian stock, trading under the symbol DOC-X on the TSX Venture Exchange (DOC-CV). It is usually referred to as TSXV:DOC or DOC-X
In the last year, there was no coverage of CloudMD published on Stockchase.
CloudMD was recommended as a Top Pick by on . Read the latest stock experts ratings for CloudMD.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered CloudMD In the last year. It is a trending stock that is worth watching.
On 2024-07-10, CloudMD (DOC-X) stock closed at a price of $0.035.
Did very well during the pandemic, a market darling then. But their acquisitions didn't make sense to him and they have caught up with them with poor integration. The hype is over and shares have plunged since 2020.